Review and analysis of inhalation dosimetry methods for application to children's risk assessment

Journal of Toxicology and Environmental Health - Part A

Volumn 68, Issue 8, 2005, Pages 573-615

  Ginsberg, Gary L ^a   Foos, Brenda Perkovich ^b   Firestone, Michael P ^b  

^a CT Dept Pub Hlth Epidem E I   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BRONCHIOLE; CHEMICAL REACTION; CHILD; DOSIMETRY; GAS; HEALTH HAZARD; HUMAN; INHALATION; LUNG; LUNG MODEL; LUNG VENTILATION; METHODOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; RISK ASSESSMENT; TRACHEOBRONCHIAL TREE;

ADMINISTRATION, INHALATION; ADULT; AGING; ANIMALS; ENVIRONMENTAL POLLUTANTS; FEMALE; GASES; HUMANS; INFANT; MALE; PARTICLE SIZE; RESPIRATORY SYSTEM;

EID: 17444374921     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/15287390590921793     Document Type: Review

References (113)

1. Alcorn, J., and McNamara, P. J. 2002. Ontogeny of hepatic and renal systemic clearance pathways in infants. Part II. Clin. Pharmacokinet. 41:1077-1094.
2. Anderson, B. J., McKee, A. D., and Holford, H. G. 1997. Size, myths, and the clinical pharmacokinetics of analgesia in pediatric patients. Clin. Pharmacokinet. 33:313-327.
3. Anderson, P. J., Wilson, J. D. and Hiller, F. C. 1990. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest 97:1115-1120.
4. Armengot, M., and Basterra, J. 1991. Nasal mucociliary function in the normal newborn. Int. J. Pediatr. Otorhinolaryngol. 22:109-113.
5. Balashazy, I., Hofmann, W., and Heistracher, T. 2003. Local particle deposition patterns may play a key role in the development of lung cancer. J. Appl. Physiol. 94:1719-1725.
6. Barry, B. E., Miller, F. J. and Crapo, J. D. 1985. Effects of inhalation of 0.12 and 0.25 ppm ozone on the proximal alveolar region of juvenile and adult rats. Lab. Invest. 53:692-704.
7. Barry, B. E., Mercer, R. R., Miller, F. J. and Crapo, J. D. 1988. Effects of inhalation of 0.25 ppm ozone on the terminal bronchioles of juvenile and adult rats. Exp. Lung Res. 14:225-245.
8. Becquemin, M. H., Yu, C. P., Roy, M., Bouchikhi, A., and Teillac, A. 1991. Total deposition of inhaled particles related to age: comparison with age-dependent model calculations. Radiat. Prot. Dosim. 38:23-28.
9. Becquemin, M. M. Bertholon, J. F., Bouchikhi, A., Malarbet, J. L., and Roy, M. 1999. Oronasal ventilation partitioning in adults and children: effect on aerosol deposition in airways. Radiat. Prot. Dosim. 81:221-228.
10. Bennett, W. D. and Zeman, K. L. 1998. Deposition of fine particles in children spontaneously breathing at rest. Inhal. Toxicol. 10:831-842.
11. Bennett, W. D., and Zeman, K. L. 2004. Effect of body size on breathing pattern and fine-particle deposition in children. J. Appl. Physiol. 97:821-826.
12. Bennett, W. D., Zeman, K. L., and Jarabek, A. M. 2003. Nasal contribution to breathing with exercise: effect of race and gender. J. Appl. Physiol. 95:497-503.
13. Bobak, M., and Leon, D. A. 1999. The effect of air pollution and infant mortality appears specific for respiratory causes in the postneonatal period. Epidemiology 10:666-670.
14. Brown, J. S., Zeman, K. L., and Bennett, W. D. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am. J. Respir. Crit. Care Med. 166:1240-1247.
15. Bush, M. L., Frederick, C. B., Kimbell, J. S., and Ultman, J. S. 1998. A CFD-PBPK hybrid model for simulating gas and vapor uptake in the rat nose. Toxicol. Appl. Pharmacol. 150:133-145.
16. Camner, P. 1971. The production and use of test aerosols for studies of human tracheobronchial clearance. Environ. Physiol. 1:137-154.
17. Chang, L. Y., Graham, J. A., Miller, F. J., Ospital, J. J., and Crapo, J. D. 1986. Effects of subchronic inhalation of low concentrations of nitrogen dioxide. I. The proximal alveolar region of juvenile and adult rats. Toxicol. Appl. Pharmacol. 83:45-61.
18. Clewell, H., Gentry, P. R., Covington, T. R., Sarangapani, R., and Teeguarden, J. G. 2004. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. 79:381-393.
19. Colebatch, H. J., and Ng, C. K. 1992. Estimating alveolar surface area during life. Respir. Physiol. 88:163-170.
20. Cresteil, T. 1998. Onset of xenobiotic metabolism in children: Toxicological implications. Food Addit. Contam. 15(suppl.):45-51.
21. Diaz-Sanchez, D., Penichet-Garcia, M., and Saxon, A. 2000. Diesel exhaust particles directly induce activated mast cells to degranulate and increase histamine levels and symptom severity. J. Allergy Clin. Immunol. 106:1140-1146.
22. Diaz-Sanchez, D., Proietti, L., and Polosa, R. 2003. Diesel fumes and the rising prevalence of atopy: An urban legend? Curr. Allergy Asthma Rep. 3:146-152.
23. Dorne, J. L. C. M., Walton, K., and Renwick, A. G. 2001. Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates. Food Chem. Toxicol. 39:681-696.
24. Dunnill, M. S. 1962. Postnatal growth of the lung. Thorax 17:329-333.
25. Escribano, A., Armengot, M. Marco, V., Basterra, J., and Brines, J. 1993. An isotopic study of nasal mucociliary transport in newborns: Preliminary investigations. Pediatr. Pulmonol. 16:167-169.
26. Evans, M. J., Fanucchi, M. V., Baker, G. L., Van Winkle, L. S., Pantle, L. M., Nishio, S. J., Schelegle, E. S., Gershwin, L. J., Miller, L. A., Hyde, D. M. Sannes, P. L., and Plopper, C. G. 2003. Atypical development of the tracheal basement membrane zone of infant rhesus monkeys exposed to ozone and allergen. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L931-L999.
27. Faustman, E. M., Silbernagel, S. M., Fenske, R. A., Burbacher, T. M., and Ponce, R. A. 2000. Mechanisms underlying children's susceptibility to environmental toxicants. Environ. Health Perspect. 108(suppl. 1):13-21.
28. Foord, N., Black, A., and Walsh, M. 1978. Regional deposition of 2.5-7.5 μm diameter inhaled particles in healthy male non-smokers. J. Aeorsol Sci. 9:343-357.
29. Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E. 1989. Partition coefficients of low-molecular weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98:87-99.
30. Gehr, P. 1987. Inhalation pathway in infants and children. In Age-related factors in radionuclide metabolism and dosimetry, Proceedings of a workshop held in Angers, France, Nov. 26-28, 1986, pp. 67-78. Dordrecht, the Netherlands: Nijhoff.
31. Gent, J. F., Triche, E. W., Holford, T. R., Belanger, K., Bracken, M. B., Beckett, W. S. and Leaderer, B. P. 2003. Association of low level ozone and fine particles with respiratory symptoms in children with asthma. J. Am. Med. Assoc. 290:1859-1867.
32. Ginsberg, G. 2003. Assessing cancer risks from short-term exposures in children. Risk Anal. 23:19-34.
33. Ginsberg, G., Hattis, D., Sonawane, B., Russ, A., Banati, P., Kozlak, M., Smolenski, S., and Goble, R. 2002. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol. Sci. 66:185-200.
34. Ginsberg, G., Hattis, D., Russ, A. and Sonawane, B. 2004. Physiologically-based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: Implications for assessing children's risks from environmental agents. J. Toxicol. Environ. Health A 67:297-329.
35. Grotberg, J. B., Sheth, B. V., and Mockros, L. F. 1990. An analysis of pollutant gas transport and absorption in pulmonary airways. J. Biomech. Eng. 112:168-176.
36. Guengerich, F., Kim, D., and Iwasaki, M. 1991. Role of human cytochrome P-450IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:168-179.
37. Ha, E.-H., Lee, J.-T., Kim, H., Hong, Y.-C., Lee, B.-E., Park, H.-S., and Christiani, D. C. 2003. Infant susceptibility of mortality to air pollution in Seoul, South Korea. Pediatrics 111:284-290.
38. Haddad, S., Restieri, C., and Krishnan, K. 1999. Physiological modeling to characterize adult-children differences in pharmacokinetics. Toxicologist 48: abstr. 657.
39. Hannigan, M. P., Cass, G. R., LaFleur, A. L., Busby, W. F., and Thilly, W. G. 1996. Seasonal and spatial variation of the bacterial mutagenicity of fine organic aerosol in Southern California. Environ. Health Perspect. 104:428-436.
40. Harvey, R. P., and Hamby, D. M. 2002. Age-specific uncertainty in particulate deposition for 1 μm AMAD particles using the ICRP 66 lung model. Health Phys. 82:807-816.
41. Hattis, D., Ginsberg, G., Sonawane, B., Smolenski, S., Russ, A., Kozlak, M., and Goble, R. 2003. Differences in pharmacokinetics between children and adults. II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal. 23:117-142.
42. Hodson W. A. 1991. Normal and abnormal structural development of the lung. In Fetal and neonatal physiology, eds. W. W. Fox and R. A. Polin, pp. 774-775. Philadelphia: W. B. Saunders.
43. Hodson, W. A. 1998. Normal and abnormal structural development of the lung. In Fetal and neonatal physiology, 2nd ed., eds, R. A. Polin and W. W. Fox, pp. 1033-1046. Philadelphia: W. B. Saunders.
44. Holt, P. G., Rowe, J., Loh, R., and Sly, P. D. 2003. Developmental factors associated with risk for atopic disease: implications for vaccine strategies in early childhood. Vaccine 21:3432-3435.
45. International Commission on Radiological Protection. 1994. Human respiratory tract model for radiological protection. ICRP Pub. No. 66.
46. International Commission on Radiological Protection. 2002. Supporting Guidance 3: Guide for the practical application of the ICRP human respiratory tract model. Ann. ICRP 32. Available from www.elsevierhealth.com.
47. Jenkins, H. A., Cool, C., Szefler, S. J., Covar, R., Brugman, S., Gelfand, E. W., and Spahn, J. D. 2003. Histopathology of severe childhood asthma. Chest 124:32-41.
48. Kedderis, G. L. 1997. Extrapolation of in vitro enzyme induction data to humans in vivo. Chem. Biol. Interact. 107:109-121.
49. Kim, C. S., Lewars, G. A., and Sackner, M. A. 1998. Measurement of total lung aerosol deposition as an index of lung abnormality. J. Appl. Physiol. 64:1527-1536.
50. Kimbell, J. S., and Subramaniam, R. P. 2001. Use of computational fluid dynamic models for dosimetry of inhaled gases in the nasal passages. Inhal. Toxicol. 13:325-334.
51. Larson, S. D., Schelegle, E. S., Walby, W. F., Gershwin, L. J., Fanuccihi, M. V., Evans, M. J., Joad, J. P., Tarkington, B. K., Hyde, D. M., and Plopper, C. G. 2004. Postnatal remodeling of the neural components of the epithelial-mesenchymal trophic unit in the proximal airways of infant rhesus monkeys exposed to ozone and allergen. Toxicol. Appl. Pharmacol. 194:211-220.
52. Lerman, J., Gregory, G. A., Willis, M. M., and Eger, E. I. 1984. Age and solubility of volatile anesthetics in blood. Anesthesiology 61:139-143.
53. Lippmann, M., and Albert, R. E. 1969. The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am. Ind. Hyg. Assoc. J. 30:257-275.
54. Lippmann, M., Yeates, D. B., and Albert, R. E. 1980. Deposition, retention and clearance of inhaled particles. Br. J. Ind. Med. 37:337-362.
55. Loomis, D., Castillejos, M., Gold, D. R., McDonnell, W., and Borja-Aburto, V. H. 1999. Air pollution and infant mortality in Mexico City. Epidemiology 10:118-123.
56. Martonen, T., Katz, I., and Cress, W. 1995. Aerosol deposition as a function of airway disease: Cystic fibrosis. Pharm. Res. 12:96-102.
57. Martonen, T. B., Musante, C. J., Segal, R. A., Schroeter, J. D., Hwang, D., Dolovich, M. A., Burton, R., Spencer, R. M., and Fleming, J. S. 2000. Lung models: Strengths and limitations. Respir. Care 45:712-736.
58. Melen, E., Wickman, M., Nordvall, S. L., van Hage-Hamsten, M., and Lindfors, A. 2001. Influence of early and current environmental exposure factors on sensitization and outcome of asthma in pre-school children. Allergy 56:646-652.
59. Mercer, R. R., Russell, M. L., Roggli, V. L. and Crapo, J. D. 1994. Cell number and distribution in human and rat airways. Am. J. Respir. Cell Mol. Biol. 10:613-624.
60. Miller, F. J., Martonen, T. B., Menache, M. G., Graham, R. C., Spektor, D. M., and Lippman, M. 1988. Influence of breathing mode and activity level on the regional deposition of inhaled particles and implications for regulatory standards. Ann. Occup. Hyg. 32(suppl. 1):3-10.
61. Miller, M. J., Martin, R. J., Carlo, W. A., Fouke, J. M., Strohl, K. P., and Fanaroff, A. A. 1985. Oral breathing in newborn infants. J. Pediatr. 107:465-469.
62. Morgan, K. T. 1994. Nasal dosimetry, lesion distribution, and the toxicologic pathologist: A brief review. Inhal. Toxicol. 6(suppl.):41-57.
63. Morris, J. B., Hassett, D. N., and Blanchard, K. T. 1993. A physiologically based pharmacokinetic model for nasal uptake and metabolism of nonreactive vapors. Toxicol. Appl. Pharmacol. 123:120-129.
64. Musante, C. J., and Martonen, T. B. 2000. Computer simulations of particle deposition in the developing human lung. J. Air Waste Manage. Assoc. 50:1426-1432.
65. National Resource Council. 1993. Pesticides in the diets of infants and children. Washington, DC: National Academy Press.
66. Nodelman, V., and Ultman, J. S. 1999a. Longitudinal distribution of chlorine absorption in human airways: comparison of nasal and oral quiet breathing. J. Appl. Physiol. 86:1984-1993.
67. Nodelman, V., and Ullman, J. S. 1999b. Longitudinal distribution of chlorine absorption in human airways: a comparison to ozone absorption. J. Appl. Physiol. 87:2073-2080.
68. Oldham, M. J., Mannix, R. C., and Phalen, R. F. 1997. Deposition of monodisperse particles in hollow models representing adult and child-size tracheobronchial airways. Health Phys. 72:827-834.
69. Overton, J. H. 2001. Dosimetry modeling of highly soluble reactive gases in the respiratory tract. Inhal. Toxicol. 13:347-357.
70. Overton, J. H., Graham, R. C., and Miller, F. J. 1987. A model of the regional uptake of gaseous pollutants in the lung. II. The sensitivity of ozone uptake in laboratory animal lungs to anatomical and ventilatory parameters. Toxicol. Appl. Pharmacol. 88:418-432.
71. Pelekis, M., Gephart, L. A., and Lerman, S. E. 2001. Physiological-model- based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. Regul. Toxicol. Pharmacol. 33:12-20.
72. Pelekis, M., Nicolich, M. J., and Gauthier, J. S. 2003. Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors. Risk Anal. 23:1239-1255.
73. Phalen, R. F., Oldham, M. J., Beaucage, C. B., Crocker, T. T., and Mortensen, J. D. 1985. Postnatal enlargement of human tracheobronchial airways and implications for particle deposition. Anat. Rec. 212:368-380.
74. Piedimonte, G. 2003. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 22(suppl. 2):S66-S74.
75. Prescott, S. L. 2003. Early origins of allergic disease: A review of processes and influences during early immune development. Curr. Opin. Allergy Clin. Immunol. 3:125-132.
76. Price, K., Haddad, S., and Krishnan, K. 2003. Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children. J. Toxicol. Environ. Health A. 66:417-433.
77. Raabe, O. G., Al-Bayati, M. A., Teague, S. V., and Rasolt, A. 1988. Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Ann. Occup. Hyg. 32(suppl.):53-63.
78. Renwick, A. G., Dorne, J. L., and Walton, K. 2000. An analysis of the need for an additional uncertainty factor for infants and children. Regul. Toxicol. Pharmacol. 31:286-296.
79. Rodenstein, D. O., Perlmutter, N. and Stanescu, D. C. 1985. Infants are not obligatory nasal breathers. Am. Rev. Respir. Dis. 131:343-347.
80. Sarangapani, R., Gentry, P. R., Covington, T. R., Teeguarden, J. G., and Clewell, H. J. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol. 15:987-1016.
81. Schelegle, E. S., Miller, L. A., Gershwin, L. J., Fanucchi, M. V., Van Winkle, L. S., Gerriets, J. E., Walby, W. F., Mitchell, V., Tarkington, B. K., Wong, V. J., Baker, G. L., Pantle, L. M., Joad, J. P., Pinkerton, K. E., Wu, R., Evans, M. J., Hyde, D. M., and Plopper, C. G. 2003. Repeated episodes of ozone inhalation amplifies the effects of allergen sensitization and inhalation on airway immune and structural development in rhesus monkeys. Toxicol. Appl. Pnarmacol. 191:74-85.
82. Schiller-Scotland, C. F., Hlawa, R., and Gebhart, J. 1994. Experimental data for total deposition in the respiratory tract of children. Toxicol. Lett. 72:137-144.
83. Schwartz, J. 2004. Air pollution and children's health. Pediatrics 113:1037-1043.
84. Seaton, A., MacNee, W., Donaldson, K., and Godden, D. 1995. Particulate air pollution and acute health effects. Lancet 345:176-178.
85. Segal., R., Kepler, G. M., Kalisak, D. L., Richardson, R. B., and Kimbell, J. S. 2004. Correlation of nasal surface-area-to-volume ratio with predicted inhaled gas uptake efficiency in humans. Abstr. 2107, Society of Toxicology Annual Meeting, March.
86. Sherwin, R. P., and Richters, V. 1985. Effect of 0.3 ppm ozone exposure on Type II cells and alveolar walls of newborn mice: an image-analysis quantitation. J. Toxicol. Environ. Health 16:535-546.
87. Smiley-Jewell, S. M., and Plopper, C. G. 2003. Proliferation during early phases of bronchiolar repair in neonatal rabbits following lung injury by 4-ipomeanol. Toxicol. Appl. Pnarmacol. 192:69-77.
88. Sonnier, M., and Cresteil, T. 1998. Delayed ontogenesis of CYP1A2 in the human liver. Eur. J. Biochem. 251:893-898.
89. Stone, K. C., Mercer, R. R., Gehr, P., Stockstill, B., and Crapo, J. D. 1992. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell Mol. Biol. 6:235-243.
90. Subramaniam, R. P., Asgharian, B., Freijer, J. I., Miller, F. J., and Anjilvel, S. 2003. Analysis of lobar differences in particle deposition in the human lung. Inhal. Toxicol. 15:1-21.
91. Tanaka, E., Terada, M., and Misawa, S. 2000. Cytochrome P450 2E1: Its clinical and toxicological role. J. Clin. Pharm. Ther. 25:165-175.
92. Thornton-Manning, J. R., Nikula, K. J., Hotchkiss, J. A., Avila, K. J., Rohrbacher, K. D., Ding, X., and Dahl, A. R. 1997. Nasal cytochrome P450 2A: Identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen. Toxicol. Appl. Pharmacol. 142:22-30.
93. Thurlbeck, W. M. 1967. The internal surface area of nonemphysematous lungs. Am. Rev. Respir. Dis. 95:765-773.
94. Thurlbeck, W. M. 1982. Postnatal human lung growth. Thorax 37:564-571.
95. U.S. Environmental Protection Agency. 1989. Risk assessment guidance for Superfund, Vol. I, Human health evaluation manual, Part A. EPA/540/1-89/002. Washington, DC: U.S. EPA.
96. U.S. Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. EPA/600/8-90/066F. Washington, DC: U.S. EPA.
97. U.S. Environmental Protection Agency. 1996. Air quality criteria for ozone and related photochemical oxidants. U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment, Washington, DC. EPA/600/P-93/004a-cF, 1996.
98. U.S. Environmental Protection Agency. 1996. Dosimetry of inhaled particles in the respiratory tract. Air quality criteria for particulate matter, EPA/600/P-95/001aF, Chapter 10. Washington, DC: U.S. EPA.
99. U.S. Environmental Protection Agency. 1999. Exposure factors handbook. EPA/600/C-99/001. Washington, DC: U.S. EPA.
100. U.S. Environmental Protection Agency. 2000. Summary report of the technical workshop on issues associated with considering developmental changes in behavior and anatomy when assessing exposure to children. Risk Assessment Forum, 10/31/2000. http://cfpub.epa.gov/ncea/raf/raf_pubtitles.cfm
101. U.S. Environmental Protection Agency. 2002. Child-specific exposure factors handbook. EPA-600-P-00-002B. Washington, DC: U.S. EPA.
102. U.S. Environmental Protection Agency. 2003a. Guidance on selecting the appropriate age groups for assessing childhood exposures to environmental contaminants. External Review Draft. EPA/630/P-03/003A. Washington, DC: U.S. EPA.
103. U.S. Environmental Protection Agency. 2003b. Supplemental guidance for assessing cancer susceptibility from early-life exposure to carcinogens. External Review Draft. EPA/630/R-03/003. Washington, DC: U.S. EPA.
104. Vieira, I., Sonnier, M., and Cresteil, T. 1996. Development expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem. 238:476-483.
105. Ward, K. A., Nicholls, D. P., and Stanford, C. F. 1993. The prevalence of preferential nasal breathing in adults. Respir. Med. 87:295-297.
106. Weibel, E. R. 1963. Morphometry of the human lung. New York: Academic Press.
107. Wiebe, B. M., and Laursen, H. 1996. Human lung volume, alveolar surface area, and capillary length. Microsc. Res. Tech. 32:256-262.
108. Woodruff, T. J., Grillo, J., and Schoendorf, K. C. 1997. The relationship between selected causes of postneonatal infant mortality and particulate air pollution in the United States. Environ. Health Perspect. 105:608-612.
109. Yadav, J., Ranga, R. K., Singh, J., and Gathwala, G. 2001. Nasal mucociliary clearance in healthy children in a tropical country. Int. J. Pediatr. Otorhinolayrngol. 57:21-24.
110. Yeh, H. C., and Schum, G. M. 1980. Models of human lung airways and their application to inhaled particle deposition. Bull. Math. Biol. 42:461-480.
111. Yu, C. P., and Koon, K. J. 1990. Retention modeling of diesel exhaust particles in rats and humans. Health Effects Inst. Report No. 40.
112. Yu, C. P., and Xu, G. B. 1987. Predicted deposition of diesel particles in young humans. J. Aerosol Sci. 18:419-429.
113. Zeltner, T. B., Caduff, J. H., Gehr, P., Pfenninger, J., and Burri, P. H. 1987. The postnatal development and growth of the human lung. I. Morphometry. Respir. Physiol. 67:247-267.